Lot-verified
Metabolic Research
Tirzepatide (Tirz / GLP 2)
≥98.9% (HPLC)Out of stock1 published lot
Tirzepatide is a dual-agonist peptide targeting both GIP and GLP-1 receptors. Used in incretin and metabolic-pathway research.
Choose size
1
- HPLC verified
- Lot-level COA
- Same-day ship
- Cold-chain
Research Use Only. Not for human or veterinary consumption. By purchasing, you certify you are a qualified researcher.
Technical specifications
Specs
All measurements verified at lot release. Handling recommendations apply to the lyophilized form prior to reconstitution.
| Purity (HPLC) | ≥98.9% (HPLC) |
|---|---|
| Molecular weight | 4813.45 g/mol |
| Form | Lyophilized powder |
| Storage | 2–8°C |
| CAS number | 2023788-19-2 |
Lot history
Published Certificates of Analysis
Every lot of Tirzepatide (Tirz / GLP 2) is independently tested before release. Click any lot to view its full COA.
Lot number
Analyzed
Expires
Purity
Lab
COA
- TP-TIRZ10-260614-010AnalyzedJul 28, 2026Expires—99.91%ILS Laboratories
